Smith & Nephew (SNN) reported a significant increase in profit and cash flow for the full year 2025, marking the successful completion of its three-year turnaround strategy. The company's fourth-quarter revenue rose by 8.3% to reach $1.7 billion, demonstrating robust momentum at the end of the fiscal year. For the full year, total revenue reached $6.2 billion, representing an increase of 6.1% compared to the previous period. Underlying revenue growth for the year stood at 5.3%, driven by strong performance across its medical device segments. Management highlighted that the completion of the strategic plan has positioned the firm for sustainable growth and improved operational efficiency. The sharp rise in cash flow is expected to bolster investor confidence in the company's financial health and future capital allocation.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis